CGMs that do not replace a blood glucose monitor are referred to as adjunctive CGMs because they can be used as an adjunct to the blood glucose monitor by showing trends in glucose levels and alerting the patient about potentially dangerous levels, even while they sleep, that then must be verified by use of a separate blood glucose monitor. The Centers for Medicare & Medicaid Services (CMS) recently issued a final rule that takes effect on Februand classifies non-implantable continuous glucose monitors (CGMs) as durable medical equipment (DME) regardless of whether the CGM has been approved or cleared by the Food and Drug Administration (FDA) to replace a blood glucose monitor for use in making diabetes treatment decisions. Information Regarding Implementation of Recent Rulemaking Addressing Classification of Adjunctive Continuous Glucose Monitors as Durable Medical Equipment (Revised)
0 Comments
Leave a Reply. |